Advancing the scientific research landscape for a specific disease or condition, especially to develop a cure or therapeutic, can be especially challenging. Learnings from broader scientific endeavors and disease-agnostic advancements can strategically inform science philanthropy. One such endeavor is the AI revolution, which has the potential to transform the health of people around the globe. Join the Science Philanthropy Accelerator for Research and Collaboration (SPARC) Philanthropic Leadership Collective for a private roundtable discussion, exploring how to guide investment to leverage technology at the intersection of AI and health care.